Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiotherapy for non-functioning pituitary adenomas.

K Boelaert1, N J Gittoes

  • 1Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK.

European Journal of Endocrinology
|May 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidelines on the Use of Systemic Therapy in Patients with Advanced Thyroid Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF.

Endocrine-related cancer·2017
Same author

Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer.

Oncogene·2017
Same author

National Osteoporosis Society practical clinical guideline on vitamin D and bone health.

Maturitas·2014
Same author

Fear of medication side effects is a barrier to optimal osteoporosis care.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2014
Same author

Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.

The Journal of clinical endocrinology and metabolism·2013
Same journal

Psychosocial retrospective follow-up of young adults with congenital adrenal hyperplasia.

European journal of endocrinology·2026
Same journal

Correction to: Steroidogenic factor-1 regulates a core set of target genes to promote malignancy in adrenocortical carcinoma.

European journal of endocrinology·2026
Same journal

Improving post-thyroidectomy care using a PTH and calcium-based algorithm.

European journal of endocrinology·2026
Same journal

Sampling variability and concordance between sequential and simultaneous adrenal venous sampling in primary aldosteronism subtype diagnosis.

European journal of endocrinology·2026
Same journal

Independent Clonal Evolution in Primary Pigmented Nodular Adrenocortical Disease: A Single-Patient Multi-Omics Study.

European journal of endocrinology·2026
Same journal

Twenty years of neurosurgical experience with Cushing's disease: surgical-strategies, endocrine outcomes and remission predictors in 346 patients.

European journal of endocrinology·2026
See all related articles

Radiotherapy (RT) after pituitary adenoma surgery may be safer than previously believed. This review assesses the risks of RT against its benefits in preventing tumor regrowth.

Area of Science:

  • Neuroendocrinology
  • Radiation Oncology
  • Neurosurgery

Background:

  • Large non-functioning pituitary adenomas often require surgical debulking.
  • Postoperative radiotherapy (RT) is used to prevent tumor recurrence.
  • Previous concerns existed regarding significant complications of pituitary RT.

Purpose of the Study:

  • To review the evidence on potential side-effects of pituitary radiotherapy.
  • To evaluate the risks of RT against its benefits in preventing tumor regrowth.

Main Methods:

  • Literature review of studies on pituitary radiotherapy.
  • Analysis of potential side-effects and clinical benefits.

Main Results:

  • Recent literature suggests pituitary RT may be less hazardous than historically perceived.

Related Experiment Videos

  • Evidence weighs the risks of RT against its efficacy in preventing tumor regrowth.

    • Conclusions:

    • Pituitary radiotherapy's safety profile may be more favorable than previously thought.
    • The benefits of preventing tumor regrowth should be considered alongside potential RT risks.